Intravitreal injection of soluble erythropoietin receptor exacerbates photoreceptor cell apoptosis in a rat model of retinal detachment

Current Eye Research

Volumn 37, Issue 12, 2012, Pages 1156-1164

  Chen, Fang ^a   Xie, Zhenggao ^a,b   Wu, Xingwei ^b   Du, Wei ^a   Wang, Jian ^a   Zhu, Jun ^a   Ji, Heqing ^a   Wang, Yakun ^a  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Apoptosis; Caspase 3; Erythropoietin; Retinal detachment; Soluble erythropoietin receptor

Indexed keywords

CASPASE 3; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT SOLUBLE ERYTHROPOIETIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MICROSCOPY; NICK END LABELING; NONHUMAN; OUTER MEMBRANE; OUTER NUCLEAR LAYER; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RAT; RETINA DETACHMENT; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IN SITU NICK-END LABELING; INTRAVITREAL INJECTIONS; MALE; PHOTIC STIMULATION; PHOTORECEPTOR CELLS, VERTEBRATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; RETINAL DETACHMENT;

EID: 84870259522     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.713156     Document Type: Article

References (39)

1. Jelkmann W, Metzen E. Erythropoietin in the control of red cell production. Ann Anat 1996;178:391-403. (Pubitemid 26364568)
2. Rex TS, Allocca M, Domenici L et al. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Mol Ther 2004;10:855-861. (Pubitemid 39419912)
3. Grimm C, Wenzel A, Stanescu D et al. Constitutive overex-pression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration. J Neurosci 2004;24:5651-5658. (Pubitemid 38857219)
4. Grimm C, Wenzel A, Groszer M et al. HIF-1-induced eryth-ropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002;8:718-724. (Pubitemid 34778725)
5. Rex TS, Wong Y, Kodali K, Merry S. Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp Eye Res 2009;89:735-740.
6. Junk AK, Mammis A, Savitz SI et al. Erythropoietin administration protects retinal neurons from acute ischemia-reper-fusion injury. Proc Natl Acad Sci USA 2002;99:10659-10664.
7. Fu QL, Wu W, Wang H et al. Upregulated endogenous eryth-ropoietin/ erythropoietin receptor system and exogenous erythropoietin rescue retinal ganglion cells after chronic ocular hypertension. Cell Mol Neurobiol 2008;28:317-329. (Pubitemid 351253068)
8. Tsai JC, Wu L, Worgul B et al. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr Eye Res 2005;30:1025-1031. (Pubitemid 43154696)
9. Tsai JC, Song BJ, Wu L et al. Erythropoietin: a candidate neu-roprotective agent in the treatment of glaucoma. J Glaucoma 2007;16:567-571. (Pubitemid 47415215)
10. Weishaupt JH, Rohde G, Pölking E et al. Effect of erythropoi-etin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 2004;45:1514-1522. (Pubitemid 38859333)
11. Kilic U, Kilic E, Soliz J et al. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J 2005;19:249-251. (Pubitemid 40189271)
12. King CE, Rodger J, Bartlett C et al. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol 2007;205:48-55. (Pubitemid 46617489)
13. Sättler MB, Merkler D, Maier K et al. Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death Differ 2004;11 Suppl 2:S181-S192.
14. Diem R, Sättler MB, Merkler D et al. Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 2005;128:375-385. (Pubitemid 40222606)
15. Zhu B, Wang W, Gu Q et al. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats. Exp Eye Res 2008;86:375-382.
16. Zhang J, Wu Y, Jin Y et al. Intravitreal injection of erythropoi-etin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 2008;49:732-742.
17. Shen J, Wu Y, Xu JY et al. ERK-and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-x L, Bax, and BAD. Invest Ophthalmol Vis Sci 2010;51:35-46.
18. Wang Q, Pfster F, Dorn-Beineke A et al. Low-dose erythropoi-etin inhibits oxidative stress and early vascular changes in the experimental diabetic retina. Diabetologia 2010;53:1227-1238.
19. Li W, Sinclair SH, Xu GT. Effects of intravitreal erythro-poietin therapy for patients with chronic and progressive diabetic macular edema. Ophthalmic Surg Lasers Imaging 2010;41:18-25.
20. Chen J, Connor KM, Aderman CM et al. Erythropoietin defciency decreases vascular stability in mice. J Clin Invest 2008;118:526-533. (Pubitemid 351206543)
21. Patel S, Rowe MJ, Winters SA et al. Elevated erythropoietin mRNA and protein concentrations in the developing human eye. Pediatr Res 2008;63:394-397. (Pubitemid 351450585)
22. Chung H, Lee H, Lamoke F et al. Neuroprotective role of erythropoietin by antiapoptosis in the retina. J Neurosci Res 2009;87:2365-2374.
23. Xie Z, Wu X, Qiu Q et al. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment. Curr Eye Res 2007;32:757-764. (Pubitemid 47450627)
24. Xie Z, Chen F, Wu X et al. Safety and effcacy of intravitreal injection of recombinant erythropoietin for protection of photoreceptor cells in a rat model of retinal detachment. Eye (Lond) 2012;26:144-152.
25. Xie Z, Chen F, Wu X et al. Effects of supplemental erythro-poietin on its receptor expression and signal transduction pathways in rat model of retinal detachment. Curr Eye Res 2012;37:138-144.
26. Wang ZY, Shen LJ, Zhao KK et al. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy. Ophthalmic Res 2009;42:138-140.
27. Westphal G, Braun K, Debus J. Detection and quantifcation of the soluble form of the human erythropoietin receptor (sEpoR) in the growth medium of tumor cell lines and in the plasma of blood samples. Clin Exp Med 2002;2:45-52. (Pubitemid 34743947)
28. Zacks DN, Hänninen V, Pantcheva M et al. Caspase activation in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 2003;44:1262-1267. (Pubitemid 36297848)
29. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004;11 Suppl 1:S37-S44. (Pubitemid 39136797)
30. Chang CJ, Lai WW, Edward DP et al. Apoptotic photoreceptor cell death after traumatic retinal detachment in humans. Arch Ophthalmol 1995;113:880-886.
31. Arroyo JG, Yang L, Bula D et al. Photoreceptor apop-tosis in human retinal detachment. Am J Ophthalmol 2005;139:605-610.
32. Cook B, Lewis GP, Fisher SK et al. Apoptotic photorecep-tor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci 1995;36:990-996.
33. Nour M, Quiambao AB, Peterson WM et al. P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci 2003;44:4505-4514. (Pubitemid 37186289)
34. Yang L, Bula D, Arroyo JG et al. Preventing retinal detachment-associated photoreceptor cell loss in Bax-defcient mice. Invest Ophthalmol Vis Sci 2004;45:648-654. (Pubitemid 38140526)
35. Berglin L, Algvere PV, Seregard S. Photoreceptor decay over time and apoptosis in experimental retinal detachment. Graefes Arch Clin Exp Ophthalmol 1997;235:306-312. (Pubitemid 27214417)
36. Faude F, Francke M, Makarov F et al. Experimental retinal detachment causes widespread and multilayered degeneration in rabbit retina. J Neurocytol 2001;30:379-390.
37. Hayashi A, Usui S, Kawaguchi K et al. Retinal changes after retinal translocation surgery with scleral imbrication in dog eyes. Invest Ophthalmol Vis Sci 2000;41:4288-4292.
38. Hisatomi T, Sakamoto T, Goto Y et al. Critical role of photo-receptor apoptosis in functional damage after retinal detachment. Curr Eye Res 2002;24:161-172. (Pubitemid 35216125)
39. Zacks DN, Zheng QD, Han Y et al. FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 2004;45:4563-4569. (Pubitemid 39564684)